7Baggers

Canopy Growth Corporation
(NASDAQ:CGC) 

CGC stock logo

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis for recreational and medical purposes primarily in Canada, the United States, Germany, and the United Kingdom. It operates through two segments, Cannabis, Hemp and Other Consumer ...

Founded: 2013
Full Time Employees: 4,434
CEO: David Klein  
Sector: Healthcare
Industry: Drug Manufacturers-Specialty & Generic
CannabisCanadian
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-06-30 2020-03-31 2020-02-14 2019-11-14 2019-08-14 2019-06-21 2019-06-20 2019-02-15 2019-02-14 2018-12-20 2018-11-15 2018-11-14 2018-11-13 2018-09-18 2018-08-15 2018-08-14 2018-06-27 
                                         
      revenue
    		82,998,000 88,748,000 77,984,000 86,244,000  75,783,000 83,153,000 90,061,000 82,076,000 121,112,000 84,331,000 113,349,000 130,359,000 122,862,000 126,123,000 155,024,000 145,648,000 155,423,000 167,375,000 169,907,000 119,088,000 439,301,442 135,546 85,621 103,391 253,431 106,485 97,703 97,703  23,327 23,327   25,916 25,916 22,806 
      yoy
    		 17.11% -6.22% -4.24%  -37.43% -1.40% -20.55% -37.04% -1.42% -33.14% -26.88% -10.50% -20.95% -24.65% -8.76% 22.30% -64.62% 123382.07% 198340.80% 115082.17% 173241.64% 27.29% -12.37% 5.82%  356.49% 318.84%   -9.99% -9.99%      
      qoq
    		-6.48% 13.80% -9.58%   -8.86% -7.67% 9.73% -32.23% 43.62% -25.60% -13.05% 6.10% -2.59% -18.64% 6.44% -6.29% -7.14% -1.49% 42.67% -72.89% 323997.68% 58.31% -17.19% -59.20% 138.00% 8.99% 0.00%   0.00%    0.00% 13.64%  
      excise taxes
    		16,315,000 16,614,000 12,953,000 11,483,000  9,571,000 10,365,000 11,556,000 12,481,000 12,386,000 10,618,000 12,136,000 12,496,000 12,747,000 14,353,000 14,052,000 14,274,000 19,214,000 18,936,000 17,379,000 8,672,000 40,820,301 11,782 9,008 12,909 27,090 12,435 14,655 14,655         
      net revenue
    		66,683,000 72,134,000 65,031,000 74,761,000 129,203,000 66,212,000 72,788,000 78,505,000 69,595,000 108,726,000 73,713,000 101,213,000 117,863,000 110,115,000 111,770,000 140,972,000 131,374,000 136,209,000 148,439,000 152,528,000 110,416,000 398,481,141 123,764 76,613 90,482 226,341 94,050 83,048 83,048         
      cost of goods sold
    		44,778,000 54,096,000 54,487,000 50,663,000  43,181,000 57,320,000 50,279,000 46,169,000 102,789,000 177,841,000 103,654,000 114,042,000 111,507,000 271,012,000 130,882,000 202,514,000 108,971,000 138,639,000 127,943,000 103,921,000                 
      gross margin
    		21,905,000 18,038,000 10,544,000 24,098,000  23,031,000 15,468,000 28,226,000 23,426,000 5,937,000 -104,128,000 -2,441,000 3,821,000 -1,392,000 -159,242,000 10,090,000 -71,140,000 27,238,000 9,800,000 24,585,000 6,495,000 -31,857,941 60,229 3,523 106,058 88,930 68,477 12,452 12,452  -33,984 -33,984 -268  41,985 41,985 7,177 
      yoy
    		 -21.68% -31.83% -14.62%  287.92% -114.85% -1256.33% 513.09% -526.51% -34.61% -124.19% -105.37% -105.11% -1724.92% -58.96% -1195.30% -185.50% 16171.23% 697742.75% 6024.01% -35923.62% -12.04% -71.71% 751.73%  -301.50% -136.64% -4746.27%  -180.94% -180.94% -103.73%     
      qoq
    		21.44% 71.07% -56.25%   48.89% -45.20% 20.49% 294.58% -105.70% 4165.79% -163.88% -374.50% -99.13% -1678.22% -114.18% -361.18% 177.94% -60.14% 278.52% -120.39% -52994.69% 1609.59% -96.68% 19.26% 29.87% 449.93% 0.00%   0.00% 12580.60%   0.00% 484.99%  
      gross margin %
    		26.39% 20.32% 13.52% 27.94% NaN% 30.39% 18.60% 31.34% 28.54% 4.90% -123.48% -2.15% 2.93% -1.13% -126.26% 6.51% -48.84% 17.53% 5.86% 14.47% 5.45% -7.25% 44.43% 4.11% 102.58% 35.09% 64.31% 12.74% 12.74% NaN% -145.69% -145.69% -Infinity% NaN% 162.00% 162.00% 31.47% 
      operating expenses
    		                     183,599.25 231,749 269,353 229,164 665,969 242,941 169,693 169,693  180,644 180,644   72,691 72,691 58,209 
      selling, general and administrative expenses
    		36,296,000 38,108,000 38,452,000 41,476,000  47,968,000 54,619,000 54,436,000 57,611,000 91,252,000 104,334,000 122,636,000 125,842,000 103,413,000 117,591,000 116,835,000 125,756,000 112,574,000 148,666,000 144,078,000 135,392,000                 
      share-based compensation
    		2,009,000 -99,000 -18,736,000 5,159,000 5,221,000 4,151,000 4,053,000 3,693,000 2,717,000 3,865,000 9,463,000 6,428,000 9,858,000 5,439,000 11,669,000 6,777,000 15,953,000 13,126,000 18,517,000 19,963,000 30,685,000                 
      loss on asset impairment and restructuring
    		494,000 2,653,000 9,098,000 1,285,000 20,830,000 20,000 63,535,000 30,413,000                              
      total operating expenses
    		38,799,000 40,662,000 28,814,000 47,920,000  52,139,000 122,207,000 88,542,000 30,433,000 97,277,000 576,327,000 151,323,000 179,668,000 1,836,837,000 370,401,000 160,051,000 144,219,000 214,949,000 243,002,000 578,198,000 178,871,000                 
      operating loss from continuing operations
    		-16,894,000 -22,624,000                                    
      other income
    		15,469,000 -18,612,000 -202,902,000 -97,758,000 -85,305,000 -93,889,000 10,629,000 -171,037,000 -128,334,000 51,497,000 -59,263,000 -113,340,000 -47,844,000 -245,578,000 -57,428,000 34,282,000 195,821,000 580,666,000 -366,770,000 -290,567,000 48,205,000 224,380,759 24,903 -109,283 32,621 -69,985 -133,451 235,231 235,231  -111,339 -111,339     -10,068 
      loss from continuing operations before income taxes
    		-1,425,000 -41,236,000                                    
      income tax expense
    		-214,000 -291,000   -302,000 -6,194,000   -12,821,000 -2,018,000    -3,749,000            -12,318           8,042 
      net income from continuing operations
    		-1,639,000 -41,527,000 -221,501,000 -121,896,000 -131,550,000 -129,191,000 -94,675,000 -230,276,000 -148,162,000                             
      discontinued operations, net of income tax
    		  713,000   2,053,000 -48,612,750 13,479,000                              
      net loss attributable to canopy growth corporation
    		-1,639,000 -41,527,000                                    
      basic and diluted loss per share
    		-0.01 -0.22 -1.47 -1.11  -1.6 -0.71 -2.62 -0.43 -0.07         -1.86 -2.43 -0.3                 
      continuing operations
    		-0.01 -0.22 -1.47 -1.11  -1.63 -0.91 -2.78 -0.21                             
      discontinued operations
    		     0.03 0.2 0.16 -0.22                             
      basic and diluted weighted-average common shares outstanding
    		274,025,102 188,321,555 107,553,729 110,306,430     716,294,433 550,459,365 463,724,414    391,324,285    371,662,296 372,908,767 363,763,347 348,038,163                
      comprehensive income:
    		                                     
      other comprehensive income, net of income tax
    		                                     
      foreign currency translation
    		6,771 6,713 9,534 -1,162  -768 -1,492 10,104 -2,369 -7,160 2,513 14,921 9,015 758 -26,585 -15,479 24,650 -27,938 -44,037 -45,809 -53,124                 
      total other comprehensive income, net of income tax
    		6,771 6,713 9,534 -1,162  -768 -2 8,750 -29,017                             
      comprehensive income from continuing operations
    		5,132  -94,762.75 -123,058  -129,959 -100,564 -221,526 -177,179                             
      comprehensive income from discontinued operations
    		  713   2,053 -48,612.75 13,479 -176,638                             
      comprehensive income attributable to canopy growth corporation
    		5,132          -627,249 -242,124 -211,542 -2,055,330 69,987 -108,204 23,012 365,140 -309,608.5 -980,279                  
      comprehensive loss from continuing operations
    		 -34,814                                    
      comprehensive loss attributable to canopy growth corporation
    		 -34,814 -211,254 -123,058  -127,906 -92,339 -208,047 -339,031 -31,103           -176,985                 
      operating income from continuing operations
    		  -24,718,250 -23,822,000  -29,108,000 -30,493,750 -60,316,000 -7,007,000                             
      income from continuing operations before income taxes
    		  -93,956,250 -121,580,000  -122,997,000 -93,811,250 -231,353,000 -135,341,000                             
      income tax (expense) recovery
    		  -329,000 -316,000         -8,220,000     -2,900,000       -14,333  -13,716 -1,041 -1,041  -284 -284 848  2,723 2,723  
      net income
    		  -220,788,000 -121,896,000  -127,138,000 -92,337,000 -216,797,000 -324,800,000 -41,861,000 -723,357,000 -266,722,000 -231,911,000 -2,087,556,000 -578,613,000 -115,496,000 -16,331,000 389,955,000 -616,695,000 -829,251,000 -128,322,000 -1,385,660,046 -124,166 -374,620 -1,281,168 -670,094 -323,362 74,860 74,860  -330,614 -330,614   -90,978 -90,978 -54,361 
      yoy
    		  139.11% -43.77%  203.71% -87.23% -18.72% 40.05% -97.99% 25.02% 130.94% 1320.07% -635.33% -6.18% -86.07% -87.27% -128.14% 496569.78% 221257.91% 9916.02% 206685.92% -61.60% -600.43% -1811.42%  -2.19% -122.64%   263.40% 263.40%      
      qoq
    		  81.13%   37.69% -57.41% -33.25% 675.90% -94.21% 171.20% 15.01% -88.89% 260.79% 400.98% 607.22% -104.19% -163.23% -25.63% 546.23% -90.74% 1115873.81% -66.86% -70.76% 91.19% 107.23% -531.96% 0.00%   0.00%    0.00% 67.36%  
      net income margin %
    		0% 0% -283.12% -141.34% NaN% -167.77% -111.04% -240.72% -395.73% -34.56% -857.76% -235.31% -177.90% -1699.11% -458.77% -74.50% -11.21% 250.90% -368.45% -488.06% -107.75% -315.42% -91.60% -437.53% -1239.15% -264.41% -303.67% 76.62% 76.62% NaN% -1417.30% -1417.30% NaN% NaN% -351.05% -351.05% -238.36% 
      discontinued operations attributable to noncontrolling interests and redeemable noncontrolling interest
    		      -4,631,500  -14,786,000                             
      net income attributable to canopy growth corporation
    		  -94,331,750 -121,896,000  -127,138,000 -141,233,000 -216,797,000 -310,014,000 -38,121,000 -641,634,250 -261,583,000 -221,806,000 -2,083,148,000 -574,616,000 -108,925,000 -11,058,000 392,418,000 -699,978,000 -904,380,000 -108,501,000                 
      fair value changes of own credit risk of financial liabilities
    		      1,490 -1,354 -26,648 14,178 -2,125 4,538 1,249 27,060 -5,100 16,200 9,420 660 -17,610 -30,090 -15,360                 
      comprehensive loss
    		  -211,254 -123,058  -127,906 -92,339 -208,047 -353,817 -34,843         -678,342 -905,150 -196,806                 
      comprehensive income from discontinued operations attributable to noncontrolling interests and redeemable noncontrolling interest
    		      -4,631.5  -14,786                             
      other expense
    		    85,305,000                              -60,426 -60,426  
      acquisition, divestiture, and other costs
    		    4,078,000                                 
      depreciation and amortization
    		    10,307,000                 10,738.25 16,530 13,644 12,779 21,510 9,870 5,015 5,015  3,595 3,595 66  3,030 3,030 4,951 
      restructuring costs recorded in cost of goods sold
    		                                     
      adjusted ebitda
    		    -5,507,000                                 
      selected consolidated financial information:
    		                                     
      gross margin percentage
    		    35,000                                 
      net loss from continuing operations attributable to canopy growth corporation
    		    -260,741,000                                 
      basic and diluted loss per share from continuing operations1, 2
    		    -3.14                                 
      1 for the six months ended september 30, 2024, the weighted-average number of outstanding common shares, basic and diluted, totaled 83,056,230 (six months ended september 30, 2023 - 63,383,000).
    		                                     
      2 prior year share and per share amounts have been retrospectively adjusted to reflect the share consolidation, which became effective on december 15, 2023.
    		                                     
      basic and diluted loss per share1
    		                                     
      basic and diluted weighted-average common shares outstanding1
    		     79,243,020 74,787,521 82,919,190                              
      income tax recovery
    		      -3,440,500 1,077,000   16,361,000 382,000   8,458,000 183,000 3,207,000  -4,945,000 15,600,000 3,038,000 121,605,389 22,451 493              
      net income from continuing operations attributable to noncontrolling interests and redeemable noncontrolling interest
    		                                     
      comprehensive income from continuing operations attributable to noncontrolling interests and redeemable noncontrolling interest
    		                                     
      (gain)/loss on asset impairment and restructuring
    		        -29,895,000                             
      discontinued operations, net of tax
    		        -176,638,000                             
      asset impairment and restructuring costs
    		         2,160,000 462,530,000 22,259,000 43,968,000 1,727,985,000 241,141,000 36,439,000 2,510,000 89,249,000 74,819,000 400,422,000 12,794,000                 
      operating income
    		         -91,340,000 -680,455,000 -153,764,000 -175,847,000 -1,838,229,000 -529,643,000 -149,961,000 -215,359,000 -187,711,000 -233,202,000 -553,613,000 -172,376,000                 
      yoy
    		         -95.03% 28.47% 2.54% -18.35% 879.29% 127.12% -72.91% 24.94%                     
      qoq
    		         -86.58% 342.53% -12.56% -90.43% 247.07% 253.19% -30.37% 14.73% -19.51% -57.88% 221.17%                  
      operating margin %
    		0% 0% 0% 0% NaN% 0% 0% 0% 0% -75.42% -806.89% -135.66% -134.89% -1496.17% -419.94% -96.73% -147.86% -120.77% -139.33% -325.83% -144.75% 0% 0% 0% 0% 0% 0% 0% 0% NaN% 0% 0% NaN% NaN% 0% 0% 0% 
      income before income taxes
    		         -39,843,000 -739,718,000 -267,104,000 -223,691,000 -2,083,807,000 -587,071,000 -115,679,000 -19,538,000 392,855,000 -611,750,000 -844,851,000 -131,360,000 -1,507,265,435 -146,617 -375,113 -1,266,835 -657,776 -309,646 75,901 75,901  -330,330 -330,330 -7,088  -93,701 -93,701 -62,403 
      net income attributable to noncontrolling interests and redeemable noncontrolling interest
    		         -3,740,000    -4,408,000 -3,997,000 -6,571,000 -5,273,000 -2,463,000 83,283,000 75,129,000 -19,821,000                 
      other comprehensive income, net of income tax effect
    		                                     
      total other comprehensive income, net of income tax effect
    		         7,018 388 19,459 10,264 27,818 -31,685 721 34,070 -27,278 -61,647 -75,899                  
      comprehensive loss attributable to noncontrolling interests and redeemable noncontrolling interest
    		         -3,740 -4,913 -5,139 -10,105 -4,408   -5,273    -19,821                 
      loss from equity method investments
    		                                     
      net loss attributable to noncontrolling interests and redeemable noncontrolling interest
    		          -4,913,000 -5,139,000 -10,105,000                         
      basic earnings per share
    		          -1.415 -0.54 -0.47 -5.23 0.175 -0.28 -0.03 1.02                    
      basic weighted-average common shares outstanding
    		           486,112,598 471,592,150 398,467,568  393,818,282 393,274,758 384,055,133                    
      diluted earnings per share
    		          -1.415 -0.54 -0.47 -5.23 0.108 -0.28 -0.03 0.84                    
      diluted weighted-average common shares outstanding
    		           486,112,598 471,592,150 398,467,568  393,818,282 393,274,758 404,546,243                    
      comprehensive income
    		          -632,162 -247,263 -221,647 -2,059,738 66,410.25 -114,775 17,739 362,677                    
      balance at march 31, 2022
    		          645,447 7,482,809 7,482,809                         
      cumulative effect from adoption of asu 2020-06
    		                                     
      other issuances of common shares and warrants
    		           82,231 60,222                         
      exercise of omnibus plan stock options
    		           1,506 1,506                         
      issuance and vesting of restricted share units and performance share units
    		           8,993                          
      changes in redeemable noncontrolling interest
    		                                     
      ownership changes relating to noncontrolling interests
    		                                     
      redemption of redeemable noncontrolling interest
    		           26,506                          
      settlement of unsecured senior notes
    		           265,265 265,265                         
      balance at december 31, 2022
    		          645,447 7,867,310                          
      issuance and vesting of restricted share units
    		            8,287                         
      balance at september 30, 2022
    		            7,818,089                         
      income from equity method investments
    		                 -100,000 -11,778,000 -671,000 -7,189,000                 
      expected credit losses on financial assets and related charges
    		                  1,000,000 13,735,000                  
      comprehensive income attributable to noncontrolling interests and redeemable noncontrolling interest
    		              -3,997 -6,571  -2,463 83,283 75,129                  
      comprehensive loss:
    		                                     
      total other comprehensive loss, net of income tax effect
    		                    -68,484                 
      inventory production costs expensed to cost of sales
    		                     60,364 81,953 86,321 77,313 175,425 79,076 64,758 64,758  16,759 16,759   14,832 14,832 14,289 
      gross margin before the undernoted
    		                     12,350.75 41,811 -9,708 13,169 50,916 14,974 18,290 18,290  6,568 6,568 -532  11,084 11,084 8,517 
      fair value changes in biological assets included in inventory sold and other charges
    		                     43,941.25 60,546 69,089    28,105 28,105  51,496 51,496      
      unrealized gain on changes in fair value of biological assets
    		                     -75,075.75 -78,964 -82,320 -139,019 -167,550 -77,050 -22,267 -22,267  -10,944 -10,944   -57,289 -57,289 -18,589 
      sales and marketing
    		                     42,953.5 62,104 60,483 45,096 154,392 53,184 44,895 44,895  39,047 39,047 925  17,266 17,266 14,751 
      research and development
    		                     10,297.75 20,795 11,922 8,474 15,238 7,274 5,264 5,264  1,944 1,944   756 756 539 
      general and administration
    		                     54,379.25 67,385 87,861 62,271 168,434 65,657 46,088 46,088  37,101 37,101 887  19,588 19,588 16,883 
      acquisition-related costs
    		                     4,750 3,256 2,562 13,182 23,394 13,788 4,520 4,520  3,202 3,202   1,884 1,884 915 
      share-based compensation expense
    		                     54,402.75 56,763 83,767 77,081 182,837 74,678 40,062 40,062  45,025 45,025   23,072 23,072 11,923 
      share-based compensation expense related to acquisition milestones
    		                     6,077.75 4,916 9,114 10,281 100,164 18,490 23,849 23,849  50,730 50,730   7,095 7,095 8,247 
      income from operations
    		                     -140,114 -171,520 -265,830 -123,106 -577,039 -174,464 -157,241 -157,241  -214,628 -214,628 -3,162  -30,706 -30,706 -51,032 
      loss on extinguishment of warrants
    		                     -294,087.5   -1,176,350             
      total other income
    		                     -307,027.25 24,903 -109,283 -1,143,729 -80,737 -135,182           
      net income attributable to:
    		                                     
      canopy growth corporation
    		                     -444,552 -120,969 -374,184 -1,283,055 -685,438 -335,607 67,582 67,582  -337,136 -337,136   -80,277 -80,277 -61,544 
      non-controlling interests
    		                     -436.5 -3,197 -436 1,887 15,344 12,245 7,278 7,278  6,522 6,522   -10,701 -10,701 7,183 
      earnings per share, basic
    		                                     
      net income per share
    		                     -1.283 -0.35 -1.08 -3.7 -2.57 -0.98 0.22 0.22  -1.52 -1.52   -0.4 -0.4 -0.31 
      weighted-average number of outstanding common shares, basic:
    		                      348,530,622     303,281,549 303,281,549  221,725,511 221,725,511      
      loss per share, diluted
    		                                     
      weighted-average number of outstanding common shares, diluted:
    		                      348,530,622      315,974,639         
      the accompanying notes are an integral part of these condensed interim consolidated financial statements.
    		                                     
      weighted-average number of outstanding common shares
    		                       347,226,921              
      fair value changes in biological assets included in inventory sold and other inventory charges
    		                        46,130 129,536 23,547        26,388 26,388 19,929 
      weighted-average number of outstanding common shares:
    		                        346,779,156 266,997,406 343,877,591        200,160,740 200,160,740 196,571,715 
      share of loss on equity investments
    		                         -10,752 -1,731 -2,089 -2,089  -4,363 -4,363   -2,569 -2,569  
      net income attributable to: - sum
    		                         -670,094 -323,362 74,860 74,860        -54,361 
      earnings per share, diluted
    		                                     
      net loss attributable to:
    		                                     
      net loss attributable to: - sum
    		                              -330,614 -330,614   -90,978 -90,978  
      earnings per share
    		                                     
      for the three months ended june 30, 2018
    		                                     
      pro forma net loss attributable to cgc
    		                                     
      weighted-average shares outstanding
    		                                     
      pro forma shares issed for acquisition
    		                                     
      pro forma weighted-average shares outstanding
    		                                     
      pro forma net loss per share
    		                                     
      for the year ended march 31, 2018
    		                                     
      pro forma weighted-average shares outstanding, basic
    		                                     
      hiku brands company ltd.
    		                                     
      retail sales
    		                                     
      retail cost of sales
    		                                     
      licensing
    		                                     
      production cost of sales
    		                                -510     
      production amortization and depreciation
    		                                -22     
      unrealized gain on change of fair value in biological assets
    		                                264     
      professional fees
    		                                275     
      stock based compensation
    		                                741     
      accretion on convertible debentures
    		                                     
      7,846
    		                                2,894     
      listing costs
    		                                -3,925     
      interest income
    		                                     
      unrealized gain on investments
    		                                     
      realized gain on investments
    		                                     
      net loss and comprehensive loss
    		                                -6,240     
      total other expense
    		                                  -62,995 -62,995  
      earnings per share, basic and diluted
    		                                     
      share of loss in equity investments
    		                                    -1,303 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-06-21 2019-06-20 2019-05-23 2019-03-31 2019-02-15 2019-02-14 2018-12-31 2018-11-15 2018-11-14 2018-11-13 2018-09-30 2018-08-15 2018-08-14 2018-06-30 2018-06-27 2018-03-31 2017-12-31 
                                                
        assets
      		                                          
        current assets:
      		                                          
        cash and cash equivalents
      		298,058,000 126,202,000 113,811,000 161,909,000 228,416,000 192,156,000 170,300,000 142,745,000 240,376,000 533,266,000 677,007,000 598,131,000 746,719,000 769,495,000 776,005,000 615,146,000 807,621,000 559,840,000 1,154,653,000 824,960,000 975,870,000 1,303,176,000 1,561,664 1,102,464 1,816,632 2,480,830 2,480,830  2,480,830 4,115,870 4,115,870 4,115,870,000 429,401 429,401  429,401 657,896 657,896 657,896 322,560 322,560,000  
        short-term investments
      		 17,427,000 17,656,000 16,435,000 2,805,000 2,766,000 33,161,000 43,436,000 30,000,000 37,802,000 105,595,000 191,119,000 396,702,000 447,620,000 595,651,000 807,884,000 1,150,325,000 1,491,286,000 1,144,563,000 768,564,000 1,060,901,000 673,323,000                     
        restricted short-term investments
      		5,651,000 5,828,000 6,410,000 7,108,000 7,490,000 7,691,000 7,310,000 7,275,000 7,990,000 9,131,000 11,765,000 12,932,000 12,352,000 12,177,000 12,216,000 12,208,000 12,219,000 14,336,000 11,332,000 11,426,000 16,436,000 21,539,000                     
        amounts receivable
      		26,862,000 50,033,000 52,780,000 49,058,000 41,860,000 50,889,000 51,847,000 63,924,000 68,856,000 128,469,000 93,987,000 104,640,000 108,236,000 96,626,000 96,443,000 100,901,000 92,630,000 106,455,000 92,435,000 93,673,000 72,578,000 90,155,000 108,822 107,487 102,766 106,974 106,974  106,974 95,476 95,476 95,476,000 45,807 45,807  45,807 27,746 27,746 27,746 21,425 21,425,000  
        inventory
      		102,373,000 93,821,000 96,373,000 90,753,000 90,094,000 84,518,000 77,292,000 86,917,000 87,470,000 142,064,000 148,901,000 213,937,000 211,209,000 205,513,000 204,387,000 365,750,000 353,309,000 411,675,000 367,979,000 394,023,000 389,800,000 391,086,000 622,575 461,757 393,738 262,105 262,105  262,105 184,961 184,961 184,961,000 150,406 150,406 244,141 150,406 118,204 118,204 118,204 101,607 101,607,000 244,141 
        prepaid expenses and other assets
      		12,872,000 10,048,000 7,544,000 15,822,000 21,000,000 19,773,000 23,232,000 23,582,000 23,462,000 32,492,000 39,999,000 52,151,000 62,957,000 62,141,000 52,700,000 86,267,000 86,905,000 91,584,000 67,232,000 78,979,000 98,362,000 85,094,000        50,439 50,439 50,439,000 56,533 56,533  56,533 36,137 36,137 36,137 19,837 19,837,000  
        total current assets
      		445,816,000 303,359,000 294,574,000 341,085,000 391,665,000 357,793,000 371,180,000 397,280,000 493,695,000 883,224,000 1,077,254,000 1,172,910,000 1,538,175,000 1,593,572,000 1,737,402,000 1,988,156,000 2,503,009,000 2,675,176,000 2,838,194,000 2,171,625,000 2,613,947,000 2,564,373,000      5,262,922,000               
        other investments
      		189,070,000 161,900,000 179,977,000                                        
        property, plant and equipment
      		288,816,000 291,274,000 293,523,000 299,604,000 303,165,000 315,022,000 320,103,000 340,479,000 346,227,000 395,206,000 499,466,000 874,029,000 864,523,000 926,369,000 942,780,000 1,080,179,000 1,123,323,000 1,142,614,000 1,074,537,000 1,148,338,000 1,508,668,000 1,524,803,000 1,725,333 1,633,303 1,429,285 1,096,340 1,096,340  1,096,340 960,158 960,158 960,158,000 661,402 661,402  661,402 479,898 479,898 479,898 303,682 303,682,000  
        intangible assets
      		81,148,000 84,330,000 87,200,000 89,791,000 95,386,000 98,956,000 104,053,000 119,072,000 148,765,000 182,942,000 188,719,000 213,530,000 223,501,000 242,479,000 252,695,000 338,753,000 342,172,000 347,063,000 308,167,000 366,375,000 444,199,000 476,366,000 567,185 514,033 528,607 519,556 519,556  519,556 168,536 168,536 168,536,000 103,867 103,867  103,867 101,723 101,723 101,723 101,526 101,526,000  
        goodwill
      		48,240,000 47,377,000 46,042,000 44,093,000 44,531,000 43,368,000 43,239,000 85,237,000 83,858,000 84,385,000 85,563,000 142,076,000 136,513,000 138,419,000 1,866,503,000 1,988,250,000 2,004,006,000 2,000,458,000 1,889,354,000 1,917,900,000 1,929,418,000 1,954,471,000 2,068,696 1,912,484 1,931,915 1,544,055 1,544,055  1,544,055 1,815,624 1,815,624 1,815,624,000 1,114,158 1,114,158  1,114,158 340,374 340,374 340,374 314,923 314,923,000  
        other assets
      		16,748,000 16,431,000 16,385,000 18,444,000 19,079,000 22,555,000 24,126,000 25,359,000 18,958,000 19,509,000 19,804,000 19,223,000 14,499,000 14,459,000 15,342,000 15,195,000 8,962,000 9,514,000 4,961,000 5,357,000 17,320,000 22,636,000                     
        total assets
      		1,069,838,000 904,671,000 917,701,000 1,164,219,000 1,232,348,000 1,286,228,000 1,300,330,000 1,359,751,000 1,668,224,000 2,190,534,000 2,439,098,000 3,020,155,000 3,402,270,000 3,517,527,000 5,615,050,000 6,309,030,000 6,490,756,000 6,966,483,000 6,823,480,000 6,309,182,000 6,845,830,000 6,857,745,000      12,693,935,000               
        liabilities and shareholders' equity
      		                                          
        current liabilities:
      		                                          
        accounts payable
      		18,136,000 24,078,000 26,099,000 28,918,000 18,364,000 25,488,000 28,673,000 25,837,000 22,724,000 57,554,000 76,234,000 63,139,000 68,203,000 64,647,000 64,270,000 67,837,000 94,367,000 91,339,000 67,262,000 86,463,000 89,368,000 123,393,000                     
        other accrued expenses and liabilities
      		39,429,000 46,535,000 38,613,000 37,191,000 42,736,000 51,293,000 54,039,000 49,775,000 51,668,000 75,425,000 75,991,000 75,985,000 88,577,000 59,913,000 75,278,000 76,007,000 86,076,000 79,938,000 100,813,000 88,419,000 82,981,000 64,994,000                     
        current portion of long-term debt
      		1,847,000 6,306,000 4,258,000 3,167,000 137,918,000 2,457,000 103,935,000     455,483,000 321,976,000 193,072,000 9,296,000 15,702,000 8,825,000 15,705,000 9,827,000 13,031,000 22,570,000 16,393,000 21,652 14,115 18,288 103,716 103,716  103,716 18,447 18,447 18,447,000 903,453 903,453  903,453 2,539 2,539 2,539 1,557 1,557,000  
        other liabilities
      		21,692,000 21,750,000 25,434,000 27,740,000 82,266,000 87,361,000 48,068,000 54,397,000 53,269,000 65,276,000 94,727,000 84,134,000 63,645,000 86,776,000 64,054,000 79,700,000 70,635,000 69,148,000 106,428,000 160,306,000 124,757,000 215,809,000                     
        total current liabilities
      		81,104,000 98,669,000 94,404,000 97,016,000 281,284,000 166,599,000 234,715,000 221,345,000 196,252,000 451,157,000 803,842,000 678,741,000 542,401,000 404,408,000 212,898,000 239,246,000 259,903,000 256,130,000 284,330,000 348,219,000 319,676,000 420,589,000      349,268,000               
        long-term debt
      		226,333,000 288,997,000 299,811,000 438,404,000 415,932,000 558,489,000 493,294,000 520,738,000 631,228,000 792,132,000 749,991,000 750,118,000 1,032,134,000 1,264,645,000 1,491,695,000 1,494,665,000 1,517,778,000 1,545,073,000 1,573,136,000 619,165,000 477,836,000 449,022,000 536,107 590,373 787,508 842,259 842,259  842,259 773,049 773,049 773,049,000 6,707 6,707  6,707 617,749 617,749 617,749 6,865 6,865,000  
        total liabilities
      		333,825,000 415,695,000 430,488,000 572,744,000 722,680,000 753,305,000 799,823,000 815,088,000 918,760,000 1,343,029,000 1,679,076,000 1,580,406,000 1,738,241,000 1,834,607,000 1,984,553,000 2,097,386,000 2,175,736,000 2,686,129,000 3,201,660,000 2,013,660,000 1,583,689,000 1,679,875,000      2,572,880,000               
        commitments and contingencies
      		                                          
        canopy growth corporation shareholders' equity:
      		                                          
        share capital common shares - nil par value; authorized - unlimited; issued and outstanding - 332,380,579 shares and 183,865,295 shares, respectively. exchangeable shares - nil par value; authorized - unlimited; issued and outstanding - 26,261,474 shares and 26,261,474 shares, respectively.
      		9,078,337,000                                          
        additional paid-in capital
      		2,614,968,000 2,614,869,000 2,618,417,000 2,637,337,000 2,620,491,000 2,617,703,000 2,602,148,000 2,578,519,000 2,575,174,000 2,500,040,000 2,506,485,000 2,510,086,000 2,516,811,000 2,515,453,000 2,519,766,000 2,482,372,000 2,485,914,000 2,413,779,000 2,415,650,000 2,509,678,000 2,520,371,000 2,615,155,000                     
        accumulated other comprehensive income
      		14,019,000                  -34,240,000 27,407,000 152,415,000 220,899,000 -45,904 -29,064 -34,057 28,630 28,630  28,630 76,584 76,584 76,584,000 -34,742 -34,742  -34,742 39,280 39,280 39,280 46,166 46,166,000  
        deficit
      		-10,971,311,000 -10,969,672,000 -10,928,145,000 -10,707,357,000 -10,585,461,000 -10,457,168,000 -10,330,030,000 -10,237,693,000 -10,020,896,000 -9,710,882,000 -9,672,761,000 -8,937,603,000 -8,676,020,000 -8,454,214,000 -6,370,337,000 -5,795,721,000 -5,686,796,000 -5,675,738,000 -6,068,156,000 -5,368,178,000 -4,431,737,000 -4,323,236,000 -3,826,095 -3,707,022 -3,334,686 -777,087 -777,087  -777,087 -441,480 -441,480 -441,480,000 -509,062 -509,062 -7,468,599 -509,062 -171,926 -171,926 -171,926 -91,649 -91,649,000 -7,468,599 
        total shareholders' equity
      		736,013,000 488,976,000 487,213,000 591,475,000 509,668,000 532,923,000 500,507,000 544,663,000 749,464,000 847,505,000 760,022,000 1,428,341,000 1,628,129,000 1,645,770,000 3,594,297,000 4,142,944,000 4,245,620,000 4,145,054,000 3,486,520,000 4,184,422,000 5,180,541,000 5,108,120,000                     
        total liabilities and shareholders' equity
      		1,069,838,000 904,671,000 917,701,000 1,164,219,000 1,232,348,000 1,286,228,000 1,300,330,000 1,359,751,000 1,668,224,000 2,190,534,000 2,439,098,000 3,020,155,000 3,402,270,000 3,517,527,000 5,615,050,000 6,309,030,000 6,490,756,000 6,966,483,000 6,823,480,000 6,309,182,000 6,845,830,000 6,857,745,000                     
        share capital common shares - nil par value; authorized - unlimited; issued and outstanding - 205,147,235 shares and 183,865,295 shares, respectively. exchangeable shares - nil par value; authorized - unlimited; issued and outstanding - 26,261,474 shares and 26,261,474 shares, respectively.
      		 8,836,531,000                                         
        accumulated other comprehensive loss
      		 7,248,000 535,000 -8,999,000 -16,032,000 -21,548,000 -16,051,000 -16,049,000 -24,799,000 -8,509,000 -13,860,000 -14,248,000 -33,707,000 -21,554,000 -42,282,000 -26,727,000 -27,448,000 -61,518,000                         
        assets of discontinued operations
      		      8,038,000 29,401,000 35,541,000                                  
        share capital common shares - nil par value; authorized - unlimited; issued and outstanding - 183,865,295 shares and 91,115,501 shares, respectively. exchangeable shares - nil par value; authorized - unlimited; issued and outstanding - 26,261,474 shares and nil shares, respectively.
      		  8,796,406,000                                        
        total canopy growth corporation shareholders' equity
      		  487,213,000 591,475,000 509,668,000 532,923,000 500,368,000 544,524,000 749,325,000 845,930,000 758,435,000 1,425,545,000 1,625,173,000 1,641,255,000 3,589,956,000 4,138,758,000 4,240,387,000 4,140,080,000 3,481,811,000 3,956,632,000 4,965,294,000 4,886,362,000                     
        noncontrolling interests
      		      139,000 139,000 139,000 1,575,000 1,587,000 2,796,000 2,956,000 4,515,000 4,341,000 4,186,000 5,233,000 4,974,000 4,709,000 227,790,000 215,247,000 221,758,000                     
        equity method investments
      		   49,834,000 136,377,000 150,669,000             100,000 16,992,000 58,654,000 65,843,000                     
        other financial assets
      		   321,368,000 242,145,000 297,865,000 437,629,000 392,324,000 556,355,000 625,268,000 568,292,000 598,387,000 625,059,000 602,229,000 800,328,000 898,497,000 509,284,000 791,658,000 708,167,000 682,595,000 273,624,000 249,253,000 351,952 449,028 746,691 363,427 363,427  363,427 281,928 281,928 281,928,000 231,387 231,387  231,387 177,282 177,282 177,282 163,463 163,463,000  
        share capital common shares - nil par value; authorized - unlimited; issued and outstanding - 129,153,014 shares and 91,115,501 shares, respectively. exchangeable shares - nil par value; authorized - unlimited; issued and outstanding - 26,261,474 shares and nil shares, respectively.
      		   8,670,494,000                                       
        share capital common shares - nil par value; authorized - unlimited; issued and outstanding - 93,863,960 shares and 91,115,501 shares, respectively. exchangeable shares - nil par value; authorized - unlimited; issued and outstanding - 26,261,474 shares and nil shares, respectively.
      		    8,490,670,000                                      
        share capital common shares - nil par value; authorized - unlimited; issued and outstanding - 80,999,437 shares and 91,115,501 shares, respectively. exchangeable shares - nil par value; authorized - unlimited; issued and outstanding - 26,261,474 shares and nil shares, respectively.
      		     8,393,936,000                                     
        noncurrent assets of discontinued operations
      		        20,366,000                                  
        liabilities of discontinued operations
      		        18,627,000                                  
        noncurrent liabilities of discontinued operations
      		        1,962,000                                  
        common shares - nil par value; authorized - unlimited number of shares; issued and outstanding - 91,115,501 shares and 51,730,555 shares, respectively1
      		      8,244,301,000                                    
        current portion of long-term debt and convertible debentures
      		       91,336,000 49,964,000 252,902,000 556,890,000                                
        common shares - nil par value; authorized - unlimited number of shares; issued and outstanding - 82,931,963 shares and 51,730,555 shares, respectively1
      		       8,219,747,000                                   
        common shares - nil par value; authorized - unlimited number of shares; issued - 829,083,667 shares and 517,305,551 shares, respectively
      		        8,219,846,000                                  
        deferred income tax liabilities
      		         1,200,000 357,000 8,988,000 9,758,000 14,658,000 15,991,000 27,366,000 25,464,000 26,570,000 21,379,000 23,251,000 45,816,000 47,113,000                     
        common shares - nil par value; authorized - unlimited number of shares; issued - 626,727,549 shares and 517,305,551 shares, respectively
      		         8,065,281,000                                 
        liability arising from acreage arrangement
      		              47,000,000 103,000,000 162,000,000 450,000,000 600,000,000 450,000,000 285,000,000 250,000,000                     
        warrant derivative liability
      		           668,000 691,000 1,555,000 26,920,000 37,491,000 104,773,000 299,318,000 615,575,000 415,946,000 287,122,000 322,491,000                     
        redeemable noncontrolling interest
      		           11,408,000 35,900,000 37,150,000 36,200,000 68,700,000 69,400,000 135,300,000 135,300,000 111,100,000 81,600,000 69,750,000                     
        common shares - nil par value; authorized - unlimited number of shares; issued - 517,305,551 shares and 394,422,604 shares, respectively
      		          7,938,571,000                                
        common shares - nil par value; authorized - unlimited number of shares; issued - 494,891,390 shares and 394,422,604 shares, respectively
      		           7,867,310,000                               
        common shares - nil par value; authorized - unlimited number of shares; issued - 480,260,882 shares and 394,422,604 shares, respectively
      		            7,818,089,000                              
        common shares - nil par value; authorized - unlimited number of shares; issued - 417,217,611 shares and 394,422,604 shares, respectively
      		             7,601,570,000                             
        common shares - nil par value; authorized - unlimited number of shares; issued - 394,422,604 shares and 382,875,179 shares, respectively
      		              7,482,809,000                            
        common shares - nil par value; authorized - unlimited number of shares; issued - 394,157,998 shares and 382,875,179 shares, respectively
      		               7,478,834,000                           
        common shares - nil par value; authorized - unlimited number of shares; issued - 393,383,061 shares and 382,875,179 shares, respectively
      		                7,468,717,000                          
        common shares - nil par value; authorized - unlimited number of shares; issued - 393,119,100 shares and 382,875,179 shares, respectively
      		                 7,463,557,000                         
        common shares - nil par value; authorized - unlimited number of shares; issued - 382,875,179 shares and 350,112,927 shares, respectively
      		                  7,168,557,000                        
        common shares - nil par value; authorized - unlimited number of shares; issued - 373,803,786 shares and 350,112,927 shares, respectively
      		                   6,787,725,000                       
        common shares - nil par value; authorized - unlimited number of shares; issued - 370,865,639 shares and 350,112,927 shares, respectively
      		                    6,724,245,000                      
        common shares - nil par value; authorized - unlimited number of shares; issued - 350,112,927 shares and 337,510,408 shares, respectively
      		                     6,373,544,000                     
        current assets
      		                                          
        marketable securities
      		                      705,921 1,633,692 1,324,255 2,034,133 2,034,133  2,034,133 799,418 799,418 799,418,000           
        biological assets
      		                      59,107 110,347 102,908 78,975 78,975  78,975 31,013 31,013 31,013,000 20,720 20,720 118,500 20,720 52,811 52,811 52,811 16,348 16,348,000 118,500 
        prepaid expenses and other current assets
      		                      114,637 152,761 124,042 107,123 107,123  107,123              
        investments in equity method investees
      		                      123,077 113,046 113,321 112,385 112,385  112,385              
        other long-term assets
      		                      37,073 34,781 31,391 25,902 25,902  25,902 32,919 32,919 32,919,000 26,776 26,776  26,776 26,973 26,973 26,973 8,340 8,340,000  
        liabilities
      		                                          
        current liabilities
      		                                          
        accounts payable and accrued liabilities
      		                      225,181 286,862 256,819 226,533 226,533  226,533 215,612 215,612 215,612,000 159,633 159,633 568,968 159,633 127,248 127,248 127,248 89,571 89,571,000 568,968 
        other current liabilities
      		                      171,476 124,853 97,647 81,414 81,414  81,414 61,357 61,357 61,357,000 27,000 27,000  27,000       
        deferred tax liability
      		                      65,733 91,026 104,118 96,031 96,031  96,031 25,703 25,703 25,703,000 30,889 30,889 484,990 30,889 30,815 30,815 30,815 33,536 33,536,000 484,990 
        share repurchase credit liability
      		                      1,301,322 1,288,079 1,274,972                  
        other long-term liabilities
      		                      194,737 207,183 212,989 140,404 140,404  140,404 122,006 122,006 122,006,000        61,150 61,150,000  
        shareholders' equity
      		                                          
        share capital
      		                      6,359,643 6,331,325 6,074,786 6,026,618 6,026,618  6,026,618 5,947,715 5,947,715 5,947,715,000 2,097,728 2,097,728  2,097,728 1,124,485 1,124,485 1,124,485 1,076,838 1,076,838,000  
        other reserves
      		                      2,768,725 2,756,749 2,902,704 1,673,472 1,673,472  1,673,472 1,645,441 1,645,441 1,645,441,000 77,905 77,905  77,905 145,564 145,564 145,564 127,418 127,418,000  
        equity attributable to canopy growth corporation
      		                      5,256,369 5,351,988 5,608,747 6,951,633 6,951,633  6,951,633 7,228,260 7,228,260 7,228,260,000 1,631,829 1,631,829  1,631,829 1,137,403 1,137,403 1,137,403 1,158,773 1,158,773,000  
        non-controlling interests
      		                      273,465 270,704 284,463 289,815 289,815 196,927,000 289,815 195,418 195,418 195,418,000 208,993 208,993  208,993 87,060 87,060 87,060 84,465 84,465,000  
        total equity
      		                      5,529,834 5,622,692 5,893,210 7,241,448 7,241,448  7,241,448 7,423,678 7,423,678 7,423,678,000 1,840,822 1,840,822  1,840,822 1,224,463 1,224,463 1,224,463 1,243,238 1,243,238,000  
        the accompanying notes are an integral part of these condensed interim consolidated financial statements.
      		                                          
        current assets - sum
      		                         5,070,140 5,070,140   5,277,177 5,277,177  702,867 702,867 17,463,351  892,794 892,794  481,777   
        current liabilities - sum
      		                         411,663 411,663   295,679 295,679  1,090,292 1,090,292   130,554 130,554  92,028   
        pro forma statement of financial position:
      		                                          
        total shareholders’ equity
      		                           10,121,055,000               
        investments in associates and joint ventures
      		                             103,773 103,773 103,773,000 136,003 136,003  136,003 93,269 93,269 93,269    
        deferred revenue
      		                             263 263 263,000 206 206  206 767 767 767 900 900,000  
        long-term financial liabilities
      		                                7,750 7,750  7,750 108,732 108,732 108,732    
        cash
      		                                  16,908,526       16,908,526 
        subscription receivable
      		                                          
        other receivables
      		                                  160,346       160,346 
        prepaids
      		                                  31,838       31,838 
        property and equipment
      		                                  5,430,720       5,430,720 
        liabilities current liabilities
      		                                          
        current portion of mortgage payable
      		                                  13,982       13,982 
        liabilities current liabilities - sum
      		                                  582,950        
        mortgage payable
      		                                  572,024       572,024 
        convertible debentures
      		                                  11,193,849       11,193,849 
        shareholders' equity share capital
      		                                  11,538,504       11,538,504 
        contributed surplus
      		                                  4,520,084       4,520,084 
        warrant reserve
      		                                  1,470,269       1,470,269 
        assets classified as held for sale
      		                                          
        investments in associates
      		                                       63,106 63,106,000  
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-08-15 2018-08-14 2018-06-30 
                                      
          cash flows from operating activities:
        		                              
          net loss
        		-1,639,000 -41,527,000 -220,788,000 -121,896,000 -128,293,000 -127,138,000 -92,337,000 -216,797,000 -324,800,000 -41,861,000                  -90,978   
          gain from discontinued operations, net of income tax
        		  713,000 0 3,257,000 2,053,000                         
          net loss from continuing operations
        		-1,639,000 -41,527,000 -221,501,000 -121,896,000 -131,550,000 -129,191,000 -94,675,000 -230,276,000                       
          adjustments to reconcile net loss to net cash from operating activities:
        		                              
          depreciation of property, plant and equipment
        		4,778,000 4,753,000 5,952,000 4,942,000 4,946,000 5,682,000 5,891,000 5,917,000 5,225,000 11,343,000 13,551,000 13,577,000 14,479,000 15,129,000 19,780,000 19,359,000 19,992,000 17,116,000 16,289,000 17,415,000 73,658,074 22,617 19,083 16,226 14,359 5,256,989,554 6,785 3,661  3,661 
          amortization of intangible assets
        		4,467,000 4,917,000 5,515,000 5,372,000 5,361,000 5,348,000 5,404,000 6,323,000 5,840,000 7,233,000 7,220,000 7,025,000 6,814,000 6,722,000 10,709,000 10,658,000 8,788,000 8,016,000 12,639,000 16,632,000 51,270,320 10,725 8,790 7,165 8,987 2,632,994,764 2,604 2,632  2,632 
          share-based compensation
        		2,009,000 -99,000 -18,736,000 5,159,000 5,221,000 4,151,000 4,053,000 3,693,000 2,569,000 3,865,000 9,463,000 6,428,000 9,858,000 5,439,000 11,669,000 6,777,000 15,953,000 13,126,000 18,517,000 30,685,000 320,034,078 61,679 92,881 87,362 93,096 64,089,869,404 99,645 30,951  30,951 
          loss on asset impairment and restructuring
        		303,000 109,000 1,314,000 203,000 18,682,000 86,000 54,613,000 25,170,000                       
          income tax expense
        		214,000 291,000 329,000 316,000 302,000 6,194,000 -1,435,000 -1,077,000 12,821,000 2,018,000  -382,000 8,220,000 3,749,000    2,900,000      14,333       
          non-cash fair value adjustments and charges related to settlement of long-term debt
        		-22,620,000 10,049,000 189,821,000 76,301,000 67,497,000 79,793,000                         
          change in operating assets and liabilities, net of effects from purchases of businesses:
        		                              
          amounts receivable
        		22,466,000 2,915,000 -1,322,000 -7,055,000 3,224,000 668,000 10,711,000 -1,557,000 23,487,000 -36,390,000 -1,709,000 3,596,000 -11,610,000 -183,000 -342,000 -8,271,000 17,300,000 -4,946,000 513,000 17,577,000           
          inventory
        		-7,992,000 2,838,000 -4,791,000 -952,000 -4,964,000 -7,008,000 9,081,000 -3,807,000 -11,077,000 6,837,000 65,188,000 -2,728,000 -5,696,000 -1,126,000 144,371,000 -11,390,000 -4,020,000 44,228,000 45,731,000 -10,772,000           
          prepaid expenses and other assets
        		-2,870,000 -2,668,000 6,360,000 5,002,000 -5,458,000 -185,000 -1,590,000 -593,000 -7,295,000 7,045,000 9,350,000 10,701,000 -8,012,000 -9,555,000 17,770,000 10,125,000 5,381,000 -8,804,000 4,430,000 -16,059,000           
          accounts payable and accrued liabilities
        		-13,186,000 5,184,000 1,516,000 5,000,000 -16,089,000 -5,911,000  13,929,000 9,483,000 -22,521,000 20,831,000 -18,044,000 30,391,000 -15,549,000 -5,080,000 -34,542,000 20,738,000 -16,960,000 -1,384,000 3,755,000           
          other, including non-cash foreign currency
        		-3,909,000 2,901,000 2,391,000 642,000 -1,024,000 -11,407,000 5,247,000 4,916,000 -24,450,000 -28,367,000 17,867,000 -5,453,000 -20,934,000 1,928,000 15,524,000 -18,043,000               
          net cash from operating activities
        		-17,979,000 -10,337,000 -33,152,000 -26,966,000 -53,852,000 -51,780,000 -22,059,000 -32,569,000 -78,651,000 -148,671,000 -139,737,000 -143,894,000 -133,400,000 -140,515,000 -126,686,000 -167,380,000 -85,965,000 -165,780,000 -97,830,000 -118,546,000 -772,086,742 -188,923 -201,045 -158,290 -225,611 -96,762,801,864 -130,495 -67,641 -67,641 -67,641 
          capital expenditures
        		0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17,337,000 0 0 0 0 0 0 0 0 0 0 
          free cash flows
        		-17,979,000 -10,337,000 -33,152,000 -26,966,000 -53,852,000 -51,780,000 -22,059,000 -32,569,000 -78,651,000 -148,671,000 -139,737,000 -143,894,000 -133,400,000 -140,515,000 -126,686,000 -167,380,000 -85,965,000 -165,780,000 -97,830,000 -101,209,000 -772,086,742 -188,923 -201,045 -158,290 -225,611 -96,762,801,864 -130,495 -67,641 -67,641 -67,641 
          cash flows from investing activities:
        		                              
          purchases of and deposits on property, plant and equipment
        		-1,226,000 -1,306,000 -3,089,000 -1,215,000 -2,589,000 -3,920,000 -249,000 -564,000 -628,000 -2,008,000 -3,041,000 -1,868,000 -2,015,000 -2,293,000 -64,000 -962,000 -15,379,000 -20,279,000 -26,525,000 -61,547,000           
          purchases of intangible assets
        		-237,000 -183,000 -58,000 -395,000 0 -14,000 169,000 87,000 -499,000 -304,000 -72,000 -327,000 -332,000 -606,000 -6,865,000 -1,835,000 -1,896,000 -833,000 -2,401,000 -3,088,000 -16,949,200 -4,186 -1,846 -1,768       
          proceeds on sale of property, plant and equipment
        		-1,000 5,000 0 0 6,000 4,926,000 299,000 1,336,000 69,092,000 83,325,000 2,715,000 110,000   1,619,000 23,370,000   15,000,000            
          redemption of short-term investments
        		17,612,000 779,000 -522,000 -13,234,000 162,000 30,022,000 10,255,000 -12,721,000 8,793,000 72,222,000                     
          net cash outflow on sale or deconsolidation of subsidiaries
        		   0 0 -6,968,000                         
          net cash inflow on loan receivable
        		  1,955,000 50,000 200,000 28,103,000                         
          investment in other financial assets
        		  0 0 0 -95,335,000 125,000 0 0 -472,000 36,000   -29,205,000 -5,000,000                
          other investing activities
        		      1,529,000 448,000 507,000 -10,189,000 1,849,000 -4,816,000   -1,367,000 -5,900,000               
          net cash from investing activities - continuing operations
        		16,729,000 -705,000 -1,714,000 -14,794,000 -2,221,000 -43,186,000                         
          net cash from investing activities - discontinued operations
        		  713,000 0 3,257,000 10,157,000 24,592,000 14,522,000                       
          net cash from investing activities
        		16,729,000 -705,000 -1,001,000 -14,794,000 1,036,000 -33,029,000 39,484,000 -611,000 60,143,000 142,574,000 91,254,000 135,125,000 85,583,000 121,417,000 301,921,000 -24,805,000 328,262,000 -374,559,000 -555,187,000 -425,984,000 -347,372,551 654,019 -529,871 -405,597 -1,442,622 -1,409,308,623,946 -193,073 -182,981 -182,981 -182,981 
          cash flows from financing activities:
        		                              
          proceeds from issuance of common shares and warrants
        		243,255,000 38,261,000 129,402,000 117,513,000 84,622,000 53,854,000 47,268,000 0   193,000 0   1,240,000 0         0      
          proceeds from exercise of stock options
        		  0 0       11,000 0 60,000 210,000 112,000 569,000 1,294,000 3,592,000 118,898,000 4,722,000 41,373,851 3,126 19,946 16,077 19,429 15,103,986,374 11,868 1,758  1,758 
          proceeds from exercise of warrants
        		  0 0               196,000 244,990,000 445,554 0 19 427 106 18,550,999,867 0 133  133 
          issuance of long-term debt and convertible debentures
        		  0 0 0 68,255,000                         
          repayment of long-term debt
        		-70,744,000 -916,000 -140,782,000 -134,765,000 -1,648,000 -11,836,000 -29,699,000 -64,895,000 -296,908,000 -118,277,000 -228,000 -117,528,000 -212,000 -211,000 -546,000 -226,000 -1,875,000 -48,116,000 -2,348,000 -6,345,000 -114,840,295 -8,423 -6,075 -98,207 -1,181 -2,855,999,357 -323 -320  -320 
          other financing activities
        		-3,514,000 -11,885,000 -4,578,000 -12,847,000 -2,598,000 -4,498,000 -9,100,000 -1,331,000 -11,075,000 -14,833,000 -8,909,000 -15,980,000 -12,073,000 -1,043,000 -1,000 0               
          net cash from financing activities
        		168,997,000 25,460,000 -15,958,000 -30,099,000 88,942,000 105,775,000 8,469,000 -66,226,000 -274,188,000 -133,110,000 126,227,000 -133,508,000 -11,369,000 -1,044,000 805,000 343,000 -1,713,000 -44,968,000 995,629,000 247,303,000     67,290 5,088,876,318,969 95,073 585,958 585,958 585,958 
          effect of exchange rate changes on cash and cash equivalents
        		4,109,000 -2,027,000 2,013,000 5,352,000 134,000 890,000 1,661,000 -824,000 2,405,000 -4,534,000 1,132,000 -6,311,000 36,410,000 13,632,000 -15,181,000 -633,000 7,197,000 -9,506,000 -12,919,000 -30,079,000 -199,635 3,940 10,315 -18,620 -34,097      
          net increase in cash and cash equivalents
        		171,856,000 12,391,000   36,260,000 21,856,000                         
          cash and cash equivalents, beginning of period
        		0 113,811,000        677,007,000 0 0 0 776,005,000 0 0 0 1,154,653,000 0 1,303,176,000  0 0 2,480,830 0 429,400,677,440 0 322,560 322,560 322,560 
          cash and cash equivalents, end of period
        		171,856,000 126,202,000        533,266,000 78,876,000 -148,588,000 -22,776,000 769,495,000 160,859,000 -192,475,000 247,781,000 559,840,000 329,693,000 975,870,000  459,200 -714,168 1,816,632 -1,635,040 4,115,869,570,599 -228,495 657,896 657,896 657,896 
          net cash from operating activities - continuing operations
        		  -33,152,000 -26,966,000 -53,852,000 -51,780,000 -22,460,000 -33,348,000                       
          net cash from operating activities - discontinued operations
        		      401,000 779,000                       
          net cash (outflow) inflow on sale or deconsolidation of subsidiaries
        		                              
          net decrease in cash and cash equivalents
        		  -48,098,000    27,555,000 -100,230,000 -290,291,000 -143,741,000 78,876,000 -148,588,000 -22,776,000 -6,510,000 160,859,000 -192,475,000 247,781,000 -594,813,000  -327,306,000           
          cash and cash equivalents, beginning of period1
        		  0 0 0 170,300,000 0 0                       
          cash and cash equivalents, end of period2
        		  -48,098,000 -66,507,000 36,260,000 192,156,000 27,555,000 -100,230,000                       
          1 includes cash of our discontinued operations of nil and 9,314 for march 31, 2024 and 2023, respectively.
        		                              
          2 includes cash of our discontinued operations of nil and nil for december 31, 2024 and 2023, respectively.
        		                              
          2 includes cash of our discontinued operations of nil and 2,599 for september 30, 2024 and 2023, respectively.
        		                              
          2 includes cash of our discontinued operations of nil and 9,816 for june 30, 2024 and 2023, respectively.
        		                              
          loss from discontinued operations, net of income tax
        		      2,338,000                        
          share of loss on equity method investments
        		              0 0 0 100,000 11,778,000 7,189,000           
          non-cash fair value adjustments and charges related to settlement of unsecured senior notes
        		      -27,984,000 144,014,000 112,893,000 -68,455,000 28,085,000 94,038,000                   
          accounts payable and other accrued expenses and accrued liabilities
        		                              
          net cash (outflow) proceeds on sale of subsidiaries
        		      2,764,000                        
          net cash outflow on acquisition of subsidiaries
        		          0    0 -5,877,000 -213,000 -8,857,000   -498,326,920 -89,128 8,996 -430,948       
          net cash from investing activities - operating activities
        		       -15,133,000                       
          loss from discontinued operations, net of tax
        		                              
          net cash proceeds on sale of subsidiaries
        		          2,500,000 0   107,825,000 0 0 10,324,000             
          asset impairment and restructuring costs
        		         10,582,000 430,135,000 14,070,000 56,907,000 1,726,877,000 219,699,000 32,560,000 -8,559,000 89,249,000 74,819,000 12,794,000           
          net income
        		          -723,357,000 -266,722,000 -231,911,000 -2,087,556,000 -578,613,000 -115,496,000 -16,331,000 389,955,000 -616,695,000 -128,322,000 -1,385,660,046 -124,166 -374,620 -1,281,168 -323,362     -90,978 
          adjustments to reconcile net income to net cash from operating activities:
        		                              
          expected credit losses on financial assets and related charges
        		                  1,000,000            
          income tax recovery
        		              -8,458,000 -183,000               
          proceeds on sale of intangible assets
        		                  0 18,337,000           
          redemption (purchases) of short-term investments
        		            57,096,000 153,996,000                 
          cash outflow on completion of riv arrangement
        		                              
          sale of equity method investments
        		                              
          investment in acreage arrangement
        		                  0            
          loan advanced to acreage hempco
        		                  0            
          (investment in) sale of other financial assets
        		                              
          non-cash fair value adjustments and charges related to settlement of convertible senior notes
        		             213,610,000                 
          net cash proceeds (outflows) on sale of subsidiaries
        		             -475,000                 
          sale of (investments in) equity method investments
        		                  0            
          non-cash fair value adjustments
        		              26,285,000 -58,934,000               
          issuance of long-term debt
        		                   4,439,000 14,750,732 4,990   0  0 600,000  600,000 
          (purchases) redemption of short-term investments
        		                  -376,222,000 -382,486,000           
          purchases of short-term investments
        		                345,898,000 -346,603,000             
          (investments in) sale of other financial assets
        		                              
          non-cash foreign currency
        		                 -17,846,000 19,184,000 8,688,000 -2,008,055 -2,482 -4,297 2,834       
          interest paid
        		                 -23,666,000 -12,763,000            
          other, including non-cash fair value adjustments
        		                 -658,248,000 323,167,000 -75,090,000           
          sale of (investments in) other financial assets
        		                 56,000             
          recovery of amounts related to construction financing
        		                  0 10,000,000           
          payment of acquisition related liabilities
        		                 -8,367,000 -1,753,000 -4,511,000           
          net cash outflow on acquisition of noncontrolling interests
        		                  0 -125,000           
          payment of share issue costs
        		                 -444,000 539,000 -595,000  -116 -55 -74 -3,029 -11,797,993,181 -6,518 -301  -301 
          proceeds from issuance of shares by riv capital
        		                              
          income tax (recovery) expense
        		                   -3,038,000      1,041,002,439 512 -2,951  -2,951 
          investments in other financial assets
        		                  -10,485,000 -2,564,000 -129,543,353 -10,224 -7,009 -29,414 -17,266 -44,375,970,305 -7,936 -21,759  -21,759 
          payment of debt issue costs
        		                              
          proceeds from issuance of shares by canopy rivers
        		                   92,000 1,170,938 906 70 86 63,758  90,431 787  787 
          investments in equity method investments
        		                              
          supplemental disclosure of cash flow information
        		                              
          cash received during the period:
        		                              
          income taxes
        		                   2,000,000           
          cash paid during the period:
        		                              
          noncash investing and financing activities
        		                              
          additions to property, plant and equipment
        		                   17,337,000           
          proceeds on assets classified as held for sale
        		                              
          change in acquisition related liabilities
        		                      0 -21,447       
          cash and cash equivalents, beginning of year
        		                              
          cash and cash equivalents, end of year
        		                              
          cash paid during the year:
        		                              
          net inflow (outflow) of cash related to the following activities:
        		                              
          operating
        		                              
          adjustments for:
        		                              
          share of loss on equity investments
        		                     2,664 2,171 1,833 1,731 2,088,993,068 4,363 2,569  2,569 
          fair value changes in biological assets included in inventory sold and other charges
        		                     60,546 69,089 46,130 23,547 28,104,922,116     
          unrealized gain on changes in fair value of biological assets
        		                     -78,964 -82,320 -139,019 -77,050 -22,266,931,767 -10,944 -57,289  -57,289 
          other assets
        		                        -2,451 1,902,018,810 -15,690 -3,120  -3,120 
          loss on extinguishment of warrants
        		                     0 0 1,176,350       
          other income and expense
        		                     -11,747 126,309 -21,400 121,705 -215,188,169,269 112,957 56,312  56,312 
          changes in non-cash operating working capital items
        		                     -107,367 -57,615 -68,936 -132,621 -40,691,911,145 -50,365 -38,490  -38,490 
          investing
        		                              
          purchases and deposits of property, plant and equipment
        		                     -170,708 -228,326 -211,824       
          redemption (purchase) of marketable securities
        		                     936,655 -299,791 687,818       
          investments in equity method investees
        		                     0 -1,895 -2,824       
          premium paid for acreage call option
        		                     0 0 -395,190       
          net cash outflow on acquisition of non-controlling interests
        		                              
          financing
        		                              
          payment of long-term debt issue costs
        		                        0  -335 -16,045  -16,045 
          payment of interest on long-term debt
        		                     -988         
          repayment of lease obligations
        		                              
          net cash (used) provided by financing activities
        		                     -9,836 6,433 -81,691       
          net cash (outflow) inflow
        		                     459,200 -714,168 -664,198       
          refer to note 23 for supplementary cash flow information
        		                              
          the accompanying notes are an integral part of these condensed interim consolidated financial statements.
        		                              
          other liabilities
        		                              
          proceeds on disposals of property and equipment
        		                              
          purchases of marketable securities
        		                        -1,227,565      
          net cash outflow on acquisition of nci
        		                              
          net cash inflow
        		                        -1,635,040 3,686,468,893,159 -228,495 335,336 335,336 335,336 
          refer to note 26 for supplementary cash flow information
        		                              
          loss on disposal of property, plant and equipment and intangible assets
        		                         -397,001,840 0 1,840  1,840 
          non-cash interest and fx impact on assets
        		                         1,804,000,410 -1,244 834  834 
          purchases and deposits of property, plant and equipment and assets in process
        		                         -202,056,706,821 -139,525 -153,654  -153,654 
          purchases of intangible assets and intangibles in process
        		                         -33,799,993,660 -3,525 -2,815  -2,815 
          investments in associates
        		                         15,238,042,439 -38,939 -3,500  -3,500 
          net cash outflow on acquisition of bc tweed nci
        		                              
          net cash outflow on acquisition of spectrum chile nci
        		                         3,000,999     
          net cash inflow (outflow) on acquisition of subsidiaries
        		                         -344,899,000,427 468 -41  -41 
          repayment of finance lease obligations
        		                         -2,623,999,896     
          purchases of restricted investments
        		                          -1,617 -1,212  -1,212 
          proceeds from issuance of common shares
        		                              
          cash flow from operating activities
        		                              
          add (deduct) items not involving cash
        		                              
          accretion and accrued interest
        		                              
          loss of change in fair value of derivative liability
        		                              
          stock-based compensation
        		                              
          amortization and depreciation
        		                              
          shares issued for services
        		                              
          change in fair value of biological assets
        		                              
          non-cash listing costs
        		                              
          deferred income tax expense
        		                              
          change in non-cash working capital
        		                              
          other receivables
        		                              
          prepaid expenses
        		                              
          inventory and biological assets
        		                              
          cash flow from financing activities
        		                              
          private placement of shares, net of issuance costs
        		                              
          issuance of convertible debentures, net of issuance costs
        		                              
          advances/repayment to related parties
        		                              
          proceeds from mortgages payable, net of repayments
        		                              
          exercise of warrants
        		                              
          repayment of mortgage payable
        		                              
          interest paid in cash
        		                              
          cash flow from financing activities - sum
        		                              
          cash flow from investing activities
        		                              
          investment in property and equipment
        		                              
          cash flow from investing activities - sum
        		                              
          increase in cash
        		                              
          cash, beginning of period
        		                              
          cash, end of period
        		                              
          fair value changes in biological assets included in inventory sold and other inventory charges
        		                           26,388  26,388 
          increase in fair value of acquisition consideration related liabilities
        		                              
          increase in finance lease obligations
        		                           -54   
          refer to note 24 for supplementary cash flow information
        		                              
          increase/(decrease) in finance lease obligations
        		                             -54